Intravenous rifampicin for persistent staphylococcal bacteremia in premature infants

Pediatrics International

Volumn 50, Issue 1, 2008, Pages 124-126

  Soraisham, Amuchou Singh ^a,b   Al Hindi, Mohammed Yasir ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

Author keywords

Bacteremia; Coagulase negative staphylococcus; Neonate; Rifampicin

Indexed keywords

AMPICILLIN; CEFAZOLIN; CEFOTAXIME; CLINDAMYCIN; CLOXACILLIN; GENTAMICIN; INDOMETACIN; NITRIC OXIDE; PENICILLIN G; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; APGAR SCORE; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BLOOD CULTURE; BRADYCARDIA; CASE REPORT; CLINICAL EXAMINATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG BLOOD LEVEL; FEEDING DISORDER; FOLLOW UP; HUMAN; INFANT; LEUKOCYTE COUNT; LIVER FUNCTION; LOW DRUG DOSE; MALE; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; PATENT DUCTUS ARTERIOSUS; PERSISTENT INFECTION; PREMATURITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RASH; RESPIRATORY DISTRESS SYNDROME; SEPSIS; SIDE EFFECT; STAPHYLOCOCCUS INFECTION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL;

ANTI-BACTERIAL AGENTS; BACTEREMIA; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFUSIONS, INTRAVENOUS; MALE; NUCLEIC ACID SYNTHESIS INHIBITORS; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN;

EID: 39049135383     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2007.02519.x     Document Type: Article

References (14)

1. Stoll BJ, Hansen N, Fanaroff AA et al. Late-onset sepsis in very low birth weight neonates: The experience of NICHD Neonatal Research Network. Pediatrics 2002 110 : 285 91.
2. Gaynes RP, Edwards JR, Jarvis WR, Culver DH, Tolson JS, Martone WJ. Nosocomial infections among neonates in high-risk nurseries in the United States. National Nosocomial Infection Surveillance System. Pediatrics 1996 98 : 357 61.
3. Tan TQ, Mason EO Jr., Ou CN, Kaplan SL. Use of intravenous rifampin in neonates with persistent staphylococcal bacteremia. Antimicrob. Agents Chemother. 1993 37 : 2401 6.
4. Shama A, Patole SK, Whitehall JS. Intravenous rifampicin in neonates with persistent staphylococcal bacteraemia. Acta Paediatr. 2002 91 : 670 73.
5. Alsayyed B. Rifampin. pediatr. Rev. 2004 25 : 216 17.
6. Khashu M, Osiovich H, Henry D, Al-Khotani A, Solimano A, Speert DP. Persistent bacteremia and severe thrombocytopenia caused by coagulase-negative Staphylococcus in a neonatal intensive care unit. Pediatrics 2006 117 : 340 49.
7. Wilson CB. Immunologic basis for increased susceptibility of the neonates to infection. J. Pediatr. 1986 108 : 1 12.
8. Fleer A, Gerards LJ, Aerts P et al. Opsonic defense to Staphylococcal epidermidis in the premature neonate. J. Infect. Dis. 1985 152 : 930 37.
9. Wright WC Jr., Ank BJ, Herbert J, Stiehm ER. Decreased bactericidal activity of leukocytes of stressed newborn infants. Pediatrics 1975 56 : 579 84.
10. Mandell GL, Vest TK. Killing of intraleukocytic Staphylococcus aureus by rifampin: In-vitro and in-vivo studies. J. Infect. Dis. 1972 125 : 486 90.
11. Acocella G, Buniva G, Flauto V, Nicolis FB. Absorption and elimination of the antibiotic rifampicin in newborns and children. In : Proceedings of the 6th International Congress of Chemotherapy, Vol. 2. University of Tokyo Press, Tokyo, 1969 755 60.
12. Raad I, Alrahwan A, Rolston K. Staphylococcus epidermidis: Emerging resistance and need for alternative agents. Clin. Infect. Dis. 1998 26 : 1182 7.
13. Karlowicz MG, Furigay PJ, Croitoru DP, Buescher ES. Central venous catheter removal versus in situ treatment in neonates with coagulase-negative staphylococcal bacteremia. Pediatr. Infect. Dis. J. 2002 21 : 22 7.
14. Raad I, Darouiche R, Dupuis J et al. Central venous catheters coated with minocycline and rifampicin for prevention of catheter-related colonization and blood stream infections. A randomized, double-blind trial. The Texas Medical Center Catheter study Group. Ann. Intern. Med. 1997 127 : 267 74.